| This article was first published on les Nouvelles, March 2026 edition. In the high-stakes biotechnology and pharmaceutical industries, and in their emerging offshoots like the fast-growing psychedelics space, patents are both a cornerstone of innovation and a potential latent source of risk. At the heart of this dynamic lie prior art and freedom-to-operate […]
Search
Subscribe for News and Updates
Footer
Search
Management Consulting
- Debt and Equity Capital Intellectual Property Valuation
- Intellectual Property Department Operations
- Intellectual Property Lifecycle Management
- Intellectual Property Strategy & Analytics
- Risk Management
- Royalty & License Compliance
- Trade Secret Management
- Valuation – Bankruptcy
- Valuation – Business Enterprise
- Valuation – Intellectual Property
- Valuation – Intellectual Property Transaction
- Valuation – Litigation Dispute
- Valuation – Merger & Acquisition
- Valuation – Patent
- Venture Development & Innovation Management
Advisory
- Corporate M&A
- Corporate Restructuring
- Intellectual Property Acquisitions
- Intellectual Property Auctions
- Intellectual Property Lifecycle Management
- Intellectual Property Transactions
- Investment Banking
- Investment Research
- Ocean Tomo Bid-Ask Market®
- Patent Indexes
- Patent Monetization Strategy
- Private Equity
- Private Sales
- Royalty Securitizations